Inventor
Zusheng XU
Inventor
CN
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds28%
A61KPreparations for medical, dental or toiletry purposes22%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
C07BGeneral methods of organic chemistry11%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium11%
Y02PClimate change mitigation technologies in the production or processing of goods6%
PatentTitleYear
12,275,727Compound containing structure of a five-membered heteroaromatic ring, pharmaceutical compositions thereof and applications thereof202511,584,745Aromatic heterocyclic compound, intermediate thereof, preparation method therefor, and pharmaceutical composition and use thereof202311,505,542Preparation method for morpholinquinazoline compound and intermediates thereof202211,466,003Nitrogenous heterocyclic aromatic compound, preparation method therefor, pharmaceutical composition thereof, and application thereof202211,447,490Aromatic heterocyclic substituted olefin compound, preparation method for same, pharmaceutical composition of same, and applications thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2023Patents assigned to SHANGHAI YINGLI PHARM CO LTD (4)· patent assignee history
2022–2025Based in CN· patent location history
2025Patents assigned to 280 BIO INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SHANGHAI YINGLI PHARM CO LTD | 4 | 2022–2023 |
| 280 BIO INC | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| CN | 5 | 2022–2025 |